Takehiro Fukami

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

Masaki Ihara, Kazuhito Noguchi, Toshihiko Saeki et al. · Life Sciences · 1992 · 877 citations

Molecular Pharmacology, Eta Receptor, Signal Transduction +12

Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice

Akio Kanatani, Satoshi Mashiko, Naomi Murai et al. · Endocrinology · 2000 · 240 citations · Full text

Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R

Andreas W. Sailer, Hideki Sano, Zhizhen Zeng et al. · Proceedings of the National Academy of Sciences · 2001 · 239 citations · Full text

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

Ngozi Erondu, Ira Gantz, Bret J. Musser et al. · Cell Metabolism · 2006 · 181 citations · Full text

Obesity, Metabolic Syndrome, Meaningful Weight Loss +12

Cyclic pentapeptide endothelin antagonists with high ETA selectivity. Potency- and solubility-enhancing modifications

Kiyofumi Ishikawa, Takehiro Fukami, Toshio Nagase et al. · Journal of Medicinal Chemistry · 1992 · 140 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14